Rocket One Inc. has signed a 12-month patent license agreement with the U.S. Department of the Air Force to evaluate a patented technology designed to capture hostile drones and isolate their communications. This technology combines physical containment with radio-frequency isolation to neutralize unmanned vehicles, potentially enhancing protection for military bases, airports, borders, and critical infrastructure. Rocket One plans to test system configurations and explore integration with its existing drone-swarm threat-emulation platform, Swarm Stage AI. The agreement grants evaluation rights only, with no current commercial sales authorized, and the technology remains under assessment.
Rocket One's patent license agreement with the U.S. Air Force is the subject, with Pluang's Technology-sector market data providing context. As of Oct 06, 2026 19:01 WIB, 132 of 150 priced Technology-sector US stocks on Pluang rose while 13 fell. Notable movers include Palo Alto Networks Inc (PANW) at USD 415.70 with a 1-day change of +2.20%, SAP SE (SAP) at USD 212.22 with +2.16%, and Fortinet Inc (FTNT) at USD 187.97 with +2.09%.
Over the past six months, Costco's stock has fallen by 10%, contrasting with the S&P 500's 17% gain. This decline has sparked debate on whether Costco's shares, now trading under $900, represent a buying opportunity. Investors are weighing if the pri...
The Bitcoin Bull Score, an index by CryptoQuant measuring market bullishness, reached 90 out of 100 on September 29, 2026, indicating a strong but not peak bullish phase. Despite this high score, spot demand for Bitcoin has declined by 170,000 BTC ov...
Citi has named NatWest Group as one of its top picks in the European banking sector, citing steady loan growth and supportive interest rates as key factors. Despite softer deposit growth and margin pressure from shifts to higher-yield term deposits, ...
NextPlat Corp has completed the acquisition of an independent pharmacy near Pensacola, Florida, for $1.49 million. The pharmacy, which generated $5.6 million in sales in 2025 and operates debt-free, will enhance NextPlat's PharmcoRx segment by expand...
A federal judge allowed a $3.2 billion ad-tech damages claim against Google to proceed to trial, with US antitrust law potentially tripling any jury award to $9.6 billion. The claim involves publishers like USA Today and the Daily Mail, alleging lost...
